Sensitive markers to detect progression of lung disease in children with cystic fibrosis

Mirjam Stahl^{1

2}

Affiliations

¹ Dept of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany mirjam.stahl@charite.de.
² German Center for Lung Research (DZL), Associated Partner Site, Berlin, Germany.

Free article

Editorial

Mirjam Stahl. Eur Respir J. 2021.

Free article

. 2021 Jul 8;58(1):2100236.

doi: 10.1183/13993003.00236-2021. Print 2021 Jul.

Mirjam Stahl^{1

2}

¹ Dept of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany mirjam.stahl@charite.de.
² German Center for Lung Research (DZL), Associated Partner Site, Berlin, Germany.

No abstract available

Conflict of interest statement

Conflict of Interest: M. Stahl has nothing to disclose.

Longitudinal course of clinical lung clearance index in children with cystic fibrosis.
Frauchiger BS, Binggeli S, Yammine S, Spycher B, Krüger L, Ramsey KA, Latzin P. Frauchiger BS, et al. Eur Respir J. 2021 Jul 8;58(1):2002686. doi: 10.1183/13993003.02686-2020. Print 2021 Jul. Eur Respir J. 2021. PMID: 33361098
Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis.
Stanojevic S, Davis SD, Perrem L, Shaw M, Retsch-Bogart G, Davis M, Jensen R, Clem CC, Isaac SM, Guido J, Jara S, France L, McDonald N, Solomon M, Sweezey N, Grasemann H, Waters V, Sanders DB, Ratjen FA. Stanojevic S, et al. Eur Respir J. 2021 Jul 8;58(1):2003380. doi: 10.1183/13993003.03380-2020. Print 2021 Jul. Eur Respir J. 2021. PMID: 33542049